Establishment and Clinical Application in Stroke of a Serum Copeptin Time-Resolved Fluorescence Immunoassay

• Published in: Journal of fluorescence Vol. 34; no. 5; pp. 2349 - 2358
• Main Authors: Zhou, Zixuan, Sun, Fan, Jiang, Jingwen, Dou, Zhijie, Lv, Yinglei, Zhang, Zhimin, Zhou, Xiumei, Zhao, Xueqin, Qin, Yuan, Huang, Biao
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.09.2024; Springer Nature B.V
• Subjects: Aged; Analytical Chemistry; Antibodies; Biochemistry; Biological and Medical Physics; Biomarkers; Biomarkers - blood; Biomedical and Life Sciences; Biomedicine; Biophysics; Biotechnology; Coefficient of variation; Female; Fluorescence; Fluoroimmunoassay - methods; Glycopeptides - blood; Hemorrhage; Humans; Immunoassay; Male; Middle Aged; Stroke; Stroke - blood; Stroke - diagnosis; Time Factors; Time-resolved fluorescence immunoassay; Cerebral infarction; Stroke; Intracerebral hemorrhage; Copeptin
• ISSN: 1053-0509; 1573-4994; 1573-4994
• DOI: 10.1007/s10895-023-03441-7

The serum biomarker copeptin, an innovative and stable substitute biomarker of vasopressin, is associated with stroke. Therefore, establishing a highly sensitive time-resolved fluorescence immunoassay for copeptin (copeptin-TRFIA) is helpful to measure stroke and evaluate its value in clinical applications. Double antibody sandwich was used to establish copeptin-TRFIA. The established method was then assessed. Two coated and Eu 3+ -labeled copeptin monoclonal specific antibodies targeting different antigen epitopes were employed. The serum fluorescence counts of patients with stroke and healthy volunteers were detected by using the well-established copeptin-TRFIA. Serum copeptin levels were measured and analyzed statistically. The actual measurement linearity range of the proposed method was 0.13–44.66 ng/mL. Copeptin-TRFIA had the inter-assay coefficient of variation (CV) of 6.49%–9.08% and the intra-assay CV of 4.75%–7.77%. Patients with cerebral infarction (CI) and intracerebral hemorrhage (ICH) had significantly higher serum copeptin levels than healthy subjects. Copeptin concentrations in the serum of patients with stroke were significantly correlated with the scores of the National Institute for Healthy Stroke Scale (NIHSS) and modified Rankin Scale (mRS). A highly sensitive copeptin-TRFIA was successfully established. Serum copeptin has a certain value in the clinical diagnosis and prognosis of stroke.